✦ LIBER ✦

Pyridoxine risks and OTC dosage restriction

Book ID: 120875049
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1998
Weight: 182 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199811460-00004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fetal Growth Restriction and Subsequent

Fetal Growth Restriction and Subsequent Pregnancy Risks

✍ Wendy L. Kinzler; Lillian Kaminsky 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Genotypic relative risks under ordered r

Genotypic relative risks under ordered restriction

✍ M.N. Chiano; D.G. Clayton 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

In mapping diseases of complex aetiology, conventional linkage approaches narrow the location of the disease susceptibility locus to quite a large region so that candidate gene association studies are then necessary to further isolate these genes. However, even in the simplest scenario where the can

Cardiovascular risks associated with low

Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC

✍ Moore, Nicholas; Salvo, Francesco; Duong, Mai; Blin, Patrick; Pariente, Antoine 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 388 KB

The place of dosage form innovation and

The place of dosage form innovation and the OTC market: The price to pay

✍ Goggin, Paul L. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 730 KB

Simultaneous Determination of Pyridoxine

Simultaneous Determination of Pyridoxine, Meclizine and Buclizine in Dosage Formulations and Human Serum by RP-LC

✍ Muhammad S. Arayne; Najma Sultana; Farhan A. Siddiqui 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 322 KB

Carbohydrate restriction and cardiovascu

Carbohydrate restriction and cardiovascular risk

✍ Jocelyne G. Karam; Fiby Nessim; Samy I. McFarlane; Richard D. Feinman 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 213 KB